JP2009535419A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535419A5
JP2009535419A5 JP2009509989A JP2009509989A JP2009535419A5 JP 2009535419 A5 JP2009535419 A5 JP 2009535419A5 JP 2009509989 A JP2009509989 A JP 2009509989A JP 2009509989 A JP2009509989 A JP 2009509989A JP 2009535419 A5 JP2009535419 A5 JP 2009535419A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
agent according
day
crofelemer
ibs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009509989A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535419A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/067739 external-priority patent/WO2007130892A2/en
Publication of JP2009535419A publication Critical patent/JP2009535419A/ja
Publication of JP2009535419A5 publication Critical patent/JP2009535419A5/ja
Pending legal-status Critical Current

Links

JP2009509989A 2006-05-01 2007-04-30 便秘型過敏性腸症候群の治療方法 Pending JP2009535419A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79707606P 2006-05-01 2006-05-01
PCT/US2007/067739 WO2007130892A2 (en) 2006-05-01 2007-04-30 Method for treatment of constipation-predominant irritable bowel syndrome

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013246845A Division JP2014058548A (ja) 2006-05-01 2013-11-29 便秘型過敏性腸症候群の治療方法

Publications (2)

Publication Number Publication Date
JP2009535419A JP2009535419A (ja) 2009-10-01
JP2009535419A5 true JP2009535419A5 (cg-RX-API-DMAC7.html) 2010-06-17

Family

ID=38668465

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009509989A Pending JP2009535419A (ja) 2006-05-01 2007-04-30 便秘型過敏性腸症候群の治療方法
JP2013246845A Pending JP2014058548A (ja) 2006-05-01 2013-11-29 便秘型過敏性腸症候群の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013246845A Pending JP2014058548A (ja) 2006-05-01 2013-11-29 便秘型過敏性腸症候群の治療方法

Country Status (18)

Country Link
US (3) US7556831B2 (cg-RX-API-DMAC7.html)
EP (2) EP2015639A4 (cg-RX-API-DMAC7.html)
JP (2) JP2009535419A (cg-RX-API-DMAC7.html)
KR (2) KR20090009292A (cg-RX-API-DMAC7.html)
AU (1) AU2007248182B2 (cg-RX-API-DMAC7.html)
CA (1) CA2650022C (cg-RX-API-DMAC7.html)
CY (1) CY1113723T1 (cg-RX-API-DMAC7.html)
DK (1) DK2241318T3 (cg-RX-API-DMAC7.html)
ES (1) ES2401366T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20130203T1 (cg-RX-API-DMAC7.html)
MX (1) MX2008013768A (cg-RX-API-DMAC7.html)
NZ (3) NZ572049A (cg-RX-API-DMAC7.html)
PL (1) PL2241318T3 (cg-RX-API-DMAC7.html)
PT (1) PT2241318E (cg-RX-API-DMAC7.html)
RS (1) RS52678B (cg-RX-API-DMAC7.html)
SG (2) SG161259A1 (cg-RX-API-DMAC7.html)
SI (1) SI2241318T1 (cg-RX-API-DMAC7.html)
WO (1) WO2007130892A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ572049A (en) 2006-05-01 2012-08-31 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
PT2529626T (pt) 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8734867B2 (en) 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
JP2012503005A (ja) * 2008-09-19 2012-02-02 インスティテュート フォア ワンワールド ヘルス イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。
JP4565219B2 (ja) * 2008-12-26 2010-10-20 アサヒビール株式会社 ポリフェノール含有顆粒またはポリフェノール含有チュアブル錠剤およびその製造方法
SG10201503255SA (en) 2009-03-04 2015-06-29 Liveleaf Inc Method and material for site activated complexing of biologic molecules
US8511216B2 (en) * 2009-03-30 2013-08-20 Kanzaki Kokyukoki Mfg. Co., Ltd. Hydraulic actuator unit
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
AU2010303577B2 (en) * 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
US20120329736A1 (en) * 2011-06-24 2012-12-27 Huang Alexander L Treatment for gastrointestinal disorders using a selective, site-activated binding system
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
EP2922557B1 (en) * 2012-11-21 2017-10-04 KBS Research, LLC Herbal supplements and methods of use thereof
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
US9510880B2 (en) 2013-08-13 2016-12-06 Zimmer, Inc. Polyaxial locking mechanism
US20170119834A1 (en) * 2014-05-29 2017-05-04 Jaguar Animal Health, Inc. Methods of Treating Diarrhea in Adult Non-Human Animals
US10282369B2 (en) * 2017-03-08 2019-05-07 Centri Technology, Inc. Fast indexing and searching of encoded documents
JP2020525407A (ja) 2017-05-31 2020-08-27 ナポ ファーマシューティカルズ インク.Napo Pharmaceuticals,Inc. 先天性下痢障害を治療するための方法及び組成物
AU2018275685B2 (en) 2017-05-31 2025-04-17 Napo Pharmaceuticals, Inc. Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome
AU2018253466B2 (en) * 2017-07-17 2019-03-28 smartDNA Pty Ltd Method of diagnosing a dysbiosis
WO2026028258A1 (ja) * 2024-07-29 2026-02-05 BGG Japan株式会社 便通改善用の組成物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE446940B (sv) 1983-02-16 1986-10-20 Carl Axel Virdalm Medel for bekempande av sjukdomstillstand i matsmeltningsapparaten innehallande skal eller ytterdelar av ber eller frukter
US4698360B1 (en) 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
EP0214317B1 (fr) 1985-08-30 1988-08-17 Societe Des Produits Nestle S.A. Produit diététique à activité dépurative et anti-diarrhéique et son procédé de préparation
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
SI9011933A (sl) 1990-10-15 1998-06-30 TANIN SEVNICA Kemična industrija p.o. Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba
US5234922A (en) 1992-09-28 1993-08-10 University Of Iowa Research Foundation Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea
JP4195728B2 (ja) * 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ,インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
AU6967198A (en) 1997-04-10 1998-10-30 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
CN1215561A (zh) * 1997-10-27 1999-05-05 邢文海 保健茶
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
CN1159054C (zh) 2002-01-22 2004-07-28 随志化 通腑止泻剂
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
US20040063695A1 (en) 2002-09-30 2004-04-01 Alan Verkman Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
US7208183B2 (en) 2002-10-05 2007-04-24 Bobrowski Paul J Methods and preparations of the latex from the croton species
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
PT2529626T (pt) 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
NZ572049A (en) 2006-05-01 2012-08-31 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
AU2010303577B2 (en) 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
JP2016505561A (ja) 2012-12-07 2016-02-25 サリックス ファーマスーティカルズ,リミテッド Hiv関連下痢を治療する方法および組成物

Similar Documents

Publication Publication Date Title
Ríos-Hoyo et al. New dietary supplements for obesity: what we currently know
CN102046185B (zh) 用于减轻体重的含1,3/1,6β葡聚糖的组合物
RU2008140167A (ru) Применение неусвояемых сахаридов для лучшей адаптации младенцев после рождения
CN101897796A (zh) 一种治疗痔疮的药物
WO2018136490A1 (en) Compositions and methods for common colds
CN103930121A (zh) 膀胱过度活动症候群预防及治疗用组合物
CA2774451C (en) Dietary supplement stimulating the male sexual function
CN104352546A (zh) 金骨莲片中药饮片组合制剂、制备方法及组合包装
CN110558561A (zh) 一种具有促进骨关节健康作用的复方组合物及其应用
CN106377605A (zh) 一种用于治疗脚气病的中药
CN103638440A (zh) 一种治疗无菌性前列腺炎的中药
CN1100554C (zh) 一种根治胃下垂的中成药
CN104000809A (zh) 一种防治冠心病心绞痛的药物组合物及其应用
JP2015507002A5 (cg-RX-API-DMAC7.html)
CN103432337B (zh) 一种中药汤剂
CN101612163A (zh) 一种治疗痔疮的中药制剂及其制备方法
CN100536893C (zh) 由桑寄生和槲寄生组成的中药复方及其用途
CN101199695B (zh) 一种治疗鼻窦炎的散剂药物
CN101683393A (zh) 一种治疗泌尿系感染的蒲公英配方
Hoffman Centrality of the GI Tract
CN103381265A (zh) 一种治疗单纯蛔虫性肠梗阻的中药
CN1127341C (zh) 一种治疗痢泻的药物
CN1172716C (zh) 一种治疗急慢性肾炎的中药
CN101194981B (zh) 一种治疗慢性中耳炎的散剂药物
Braun Psyllium Plantago spp